Clinical Trial

Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCI

Completed Phase 1/2
View on ClinicalTrials.gov →
Summary
The main purposes of this study are to (1) measure the effect of CBD/CBD-A on pain symptoms, pain intensity, pain unpleasantness, and skin sensitivity to hot and cold temperatures; and (2) measure the effect of CBD on brain electrical activity with electroencephalography (EEG).
Protocol Amendment History 3 changes
critical Trial completed 2026-08-15
notable Primary completion moved earlier: 2026-09-30 -> 2026-08-13 2026-08-15
minor Completion moved earlier: 2026-09-30 -> 2026-08-13 2026-08-15
Trial Details
NCT Number NCT05630235
Lead Sponsor University of Miami
Collaborators: Consortium for Medical Marijuana Clinical Outcomes Research
Conditions SCI - Spinal Cord Injury, Neuropathic Pain
Enrollment 6 participants
Start Date 2025-06-16
Primary Completion 2026-08-13 (estimated)
Study Completion 2026-08-13 (estimated)
Updated on ClinicalTrials.gov 2026-08-14